Britain Reconsiders NHS Data Deal with Palantir

The UK government is reviewing its contract with Palantir for NHS data analytics, due for renewal in 2027. Concerns include patient confidentiality, supplier dependency, and Palantir's connections to the U.S. military. A parliamentary committee urges contract termination, emphasizing risks in relying on few U.S. tech firms.

Britain is reassessing its National Health Service's contract with U.S. data firm Palantir amidst political pressure surrounding patient confidentiality and supplier dependency. Technology Minister Liz Kendall announced on Tuesday that the review will determine whether to extend the £330 million contract due in early 2027.

MPs have criticized the contract, pointing to the increased role of Palantir in public service, potentially making NHS services vulnerable. Concerns have also been voiced about Palantir's connections to U.S. military and immigration sectors, as well as the political views of its co-founder, Peter Thiel.

Campaigners, unions, and even London Mayor Sadiq Khan have warned against the implications of this partnership, stressing the need to evaluate the ethics of companies involved in public procurement. The NHS has defended Palantir's efficacy but remains under scrutiny.